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Fetal Programming of Diabetes: Still So
Much to Learn!
I
n the preinsulin era, pregnancy in a di-
abetic mother had a bleak outcome for
both the mother and the baby. Avail-
ability of insulin and modern methods of
treatment improved the survival of these
babies, but they appear to be at increased
risk of obesity and diabetes (1–3). Spread
of the diabetes pandemic to the young
meansthereisnowagrowingepidemicof
gestational diabetes mellitus (GDM). This
label encompasses all varieties of diabetes
that happen to be diagnosed during preg-
nancy, but the majority of GDM cases
have type 2 pathology and metabolic syn-
drome–like features. There is a tacit as-
sumption that glucose intolerance may
have arisen de novo, but this is unlikely.
The majority of women have risk factors
dating back before pregnancy, sometimes
traceabletoearlylifegrowthanddevelop-
ment (4,5), and many continue to be di-
abetic after delivery or develop diabetes
soon after (6). The degree of glucose in-
tolerance qualifying for the diagnosis of
GDM is still being debated, and there is
little consideration of other metabolic pa-
rameters, such as lipids, in the diagnosis.
There is a growing realization that even a
mild change in the intrauterine environ-
ment inﬂuences the baby’s prospects not
only in the perinatal period but over the
entire length of its life (7). These ideas are
at the core of the emerging specialty of
Developmental Origins of Health and
Disease (DOHaD) (8). The process inﬂu-
encing long-term fetal outcomes is called
fetal programming (9).
The conceptus begins its life as a bag
of genes that directs the development of a
new individual. The new and important
realization is that the intrauterine envi-
ronment dictates how these genes func-
tion. A small change in this environment
has the potential to permanently alter the
working of genes and therefore the struc-
ture and function of the developing sys-
tem. These processes, which govern
evolution of an individual phenotype
from the genome, are called “epigenetic”
(10) and involve chemical modiﬁcations
in the structure of chromatin, through ei-
ther methylation of DNA or acetylation of
histones, that inﬂuence gene expression.
Noncoding RNAs (iRNA) also play a part
in regulation of gene expression. In ani-
mals, such chemical modiﬁcations alter
the phenotype despite the inheritance of
the same genotype (11). This is distinct
from the change in the sequence of base
pairs (polymorphisms or mutations) that
form the basis of genetic inﬂuence.
Our knowledge of the role of mater-
nal diabetes in fetal programming owes
itself to Jorgen Pedersen from Copenha-
gen and Norbert Freinkel and colleagues
from Chicago. A combination of their
ideas saw the birth of the concept of fuel-
mediatedteratogenesis(12)andextended
the use of this term from disﬁguring birth
defects to a wide range of changes in the
body habitus of the developing fetus. Fu-
els included glucose, fatty acids, and
amino acids and were components of the
culture medium bathing the fetus. Non-
glucose metabolites have been forgotten
in clinical practice, and the importance of
micronutrients was realized only recently
(13).
Pedersen highlighted the striking ad-
iposity of an infant of a diabetic mother
(IDM): “Most conspicuous is obesity, the
round cherub’s cheeks, buried eyes, and
short neck” (14). He ascribed this to fetal
hyperglycemia and hyperinsulinemia
stimulating excess growth of insulin-
sensitive tissues to cause macrosomia.
Clinicians are aware of the mechanical
andmetabolicproblemsforamacrosomic
baby at birth. However, the most intrigu-
ing aspect of the story unfolded during
their follow-up in Chicago (15) and in
Arizona Pima Indians (1–3), which dem-
onstrated that IDMs had an increased risk
of obesity and glucose intolerance, usu-
ally demonstrable by late childhood and
independent of maternal genetic inﬂu-
ence. Over half the cases of diabetes in
young Pima Indians were estimated to be
attributable to maternal diabetes. The rel-
ative role of genetics and epigenetic pro-
gramming in the etiology of diabetes
pandemic awaits further investigation.
Against this background, when Hales
and Barker described an association be-
tween low birth weight and type 2 diabe-
tes(16),itwasmetwithsomeskepticism.
They suggested that intrauterine under-
nutrition programmed the fetus for di-
abetes. Subsequent studies revealed
that the real shape of this relationship
was U shaped, i.e., both low and high
birth weight increased risk of type 2 di-
abetes (17,18). It is important to under-
stand that the story is not about birth
weight but about fetal programming,
andthatintergenerationalpreventionof
type 2 diabetes (primordial prevention)
will need to target maternal nutrition
and metabolism.
Thecontributionofmaternaldiabetes
to offspring obesity and diabetes outside
of the high-risk populations remains
sparsely investigated. There are many un-
answered questions: What is the role of
maternal obesity? What is the contribu-
tion of glucose, lipids, and other metabo-
lites (alone or in combination)? What are
the differences by type of maternal diabe-
tes(type1,2,GDM,andother)?Whatare
the critical windows of exposure? How
does maternal undernutrition interact
withmaternaldiabetes?Doestreatmentof
GDM reduce fetal programming?...a n d
many more. A recent report from Copen-
hagen provided some answers (19).
Clausen et al. followed 597 offspring of
diabetic mothers at 22 years of age and
compared them with a background pop-
ulation. They found that maternal hyper-
glycemia(GDM),maternalriskfactorsfor
diabetes even in absence of GDM (family
historyofdiabetes,prepregnancyobesity,
history of previous GDM, or a macro-
somic baby), and type 1 diabetes all in-
creased risk of type 2 diabetes and pre-
diabetes in the child. Maternal GDM
increased the risk by eight times, while
type 1 diabetes increased the risk four
times above the background population.
Interestingly, mothers with risk factors
but no GDM also increased the risk four
times. The degree of maternal hypergly-
cemia in the third trimester in type 1 dia-
betic mothers was a signiﬁcant predictor
of the child’s glucose tolerance. They in-
terpretedthisasmeaningthatgeneticpre-
disposition and maternal hyperglycemia
had contributed similarly to the risk of di-
abetes in the offspring (19).
This issue of Diabetes Care includes
articles that add further information (20–
23). They address a variety of maternal
exposures and offspring outcomes. All
agree that maternal hyperglycemia (irre-
spective of type of diabetes) promotes
macrosomia.TheHyperglycemiaandAd-
verse Pregnancy Outcome (HAPO) study
showed that this relationship is continu-
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In the Belfast center of the HAPO study,
maternal glycemia had only a weak effect
onoverweightandobesityintheoffspring
at 2 years of age (20), while in Scotland
type 1 diabetes had a signiﬁcant effect on
overweight and obesity at 7 years of age
(21). These results could be viewed in re-
lation to a previous observation that the
macrosomic IDMs catch down during in-
fancy, only to catch up at the time of ad-
iposity, rebound, and become obese.
Against this background, the report on
the follow up of children in the ACHOIS
trial is interesting (22). In this trial, GDM
was diagnosed in the third trimester and
randomly allocated to intensive or con-
ventional treatment. Intensive treatment
signiﬁcantly reduced macrosomia and re-
lated problems at the time of delivery but
hadnoeffectonoverweightandobesityat
5 years of age; both groups were more
obese than the background population
(22). Despite lower birth weight, at 5
years children in the intensive group had
similar weight and BMI as those in the
conventional treatment group, raising the
possibility that these children had an ear-
lier adiposity rebound. Did intensive
treatment introduce an element of intra-
uterine growth restriction that promoted
a childhood catch up? Only time will tell,
but this issue has been raised before (25).
Follow up of 16 year olds in the Northern
Finnish Birth Cohort 1986 showed that
maternal prepregnancy obesity is a more
potent determinant of offspring over-
weight and obesity compared with ma-
ternal hyperglycemia (23). Maternal
gestationalhyperglycemiabyitselfhadno
effect, but in combination with obesity
was very detrimental. These observations
highlightacrucialroleforthepericoncep-
tional environment in fetal programming
of obesity, and indirectly raise the possi-
bility that nonglucose metabolic abnor-
malities of obesity (fatty acids and lipids)
maybeimportant.Perhapswegestational
diabetologists have become too gluco-
centric? Together, these studies raise a
concern that the current practice of diag-
nosing gestational hyperglycemia in late
pregnancymightbeboltingthedoorafter
the horse has ﬂed. In our attempts to im-
prove perinatal outcomes, we should not
ignore the long-term outcomes that have
a bearing on the diabetes pandemic.
Researchers in India, myself in-
cluded, have focused their attention on
maternal micronutrient nutrition and off-
spring body composition (8). Indian ba-
biesare“‘thin-fat,”i.e.,havelessleanmass
but more fat mass compared with British
babies (26). At least part of this pheno-
type results from a maternal imbalance of
vitamin B12 and folate nutrition. Mater-
nal homocysteine concentrations pre-
dicted fetal growth restriction, and low
maternalvitaminB12andhighfolatepre-
dicted higher insulin resistance in the
child (13), thus contributing to the con-
cept of nutrient-mediated teratogenesis
(27). In Mysore, vitamin B12 deﬁciency
was associated with gestational glucose
intolerance(28),andbabiesborntoGDM
mothers had heightened risk of adiposity
and glucose intolerance at 5 years of age
(29), suggesting that a dual teratogenesis
(due to simultaneous occurrence of




Prevention of fetal programming of
diabetes will need to concentrate on the
healthofyounggirls.Deﬁnitionofcritical
periods in fetal programming will guide
us to the windows of opportunity, which
may be pre- and periconceptional, gesta-
tional, and even lactational. These issues
were highlighted at a meeting in the
United Nations (Women, Development
and Diabetes) (30) and form the core of
the “Kathmandu Declaration” which of-
fers a new interpretation of the blue circle
of the International Diabetes Federation
byrecommendinga“life-circle”approach
to prevention and treatment of diabetes,
(31).
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